Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
65.37 USD | +0.15% | -1.83% | -19.10% |
04:23pm | Jefferies Adjusts Gilead Sciences' Price Target to $80 From $95 | MT |
04:13pm | RBC Capital Adjusts Gilead Sciences' Price Target to $74 From $76 | MT |
Financials (USD)
Sales 2024 * | 27.54B | Sales 2025 * | 27.98B | Capitalization | 81.39B |
---|---|---|---|---|---|
Net income 2024 * | 2.93B | Net income 2025 * | 6.76B | EV / Sales 2024 * | 3.57 x |
Net Debt 2024 * | 16.88B | Net Debt 2025 * | 9.29B | EV / Sales 2025 * | 3.24 x |
P/E ratio 2024 * |
27.2
x | P/E ratio 2025 * |
12
x | Employees | 18,000 |
Yield 2024 * |
4.78% | Yield 2025 * |
4.99% | Free-Float | 99.9% |
Latest transcript on Gilead Sciences, Inc.
1 day | +0.31% | ||
1 week | -2.52% | ||
Current month | -11.15% | ||
1 month | -10.12% | ||
3 months | -18.16% | ||
6 months | -17.10% | ||
Current year | -19.66% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel O'Day
CEO | Chief Executive Officer | 58 | 19-02-28 |
Andrew Dickinson
DFI | Director of Finance/CFO | 54 | 15-12-31 |
Flavius Martin
CTO | Chief Tech/Sci/R&D Officer | - | 21-04-11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Anthony Welters
BRD | Director/Board Member | 69 | 20-10-16 |
Director/Board Member | 71 | 17-12-31 | |
Ted Love
BRD | Director/Board Member | 65 | Jan. 31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
13.99% | 215 M€ | +10.95% | - | |
8.10% | 0 M€ | 0.00% | - | |
8.06% | 0 M€ | 0.00% | - | |
5.23% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 65.6 | +0.51% | 3 024 118 |
24-04-25 | 65.27 | -2.70% | 15,171,959 |
24-04-24 | 67.08 | +0.07% | 8,467,060 |
24-04-23 | 67.03 | +0.12% | 5,240,249 |
24-04-22 | 66.95 | +0.28% | 5,622,367 |
Delayed Quote Nasdaq, April 26, 2024 at 10:09 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.66% | 81.39B | |
+25.69% | 653B | |
+26.30% | 556B | |
-6.36% | 354B | |
+20.57% | 331B | |
+4.58% | 296B | |
+12.49% | 233B | |
+5.53% | 201B | |
-9.69% | 193B | |
-5.94% | 144B |
- Stock Market
- Equities
- GILD Stock